Health & Safety Industry Today
Synthetic Biology Global Market 2018: Key Players – Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc.
Description
Wiseguyreports.Com Adds “Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
DNA is an industrial and medical wonder material of the 21st Century: This polymer is the core material of synthetic biology. Synthetic biology encompasses all aspects of DNA, including its reading, writing, and editing. For example, DNA editing tools like CRISPR or zinc finger nucleases are changing synthetic biology and driving market applications and growth.
These tools enable both development of novel cell lines and synthesis of important proteins. The combination of gene-editing tools and host engineering platforms enables development of new proteins more effectively.
Innovations in CRISPR gene editing tools promise to transform this field, including nano-particle delivery of CRISPR systems (MIT) and non-Cas9 gene editing.
In November 2017 Sangamo, a gene editing company, announced treatment of the first patient to undergo in-vivo gene editing for Hunters Syndrome. This was the first time that a patient received therapy to edit DNA of cells directly inside of the body. This marked a new era in gene editing because the edited DNA is integrated permanently into the patient’s DNA. Sangamo’s in vivo gene editing product candidates have received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration.
This report examines the dynamic synthetic-biology industry, including its technologies and global markets, and notes the leading companies in each of the market segments.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820006-synthetic-biology-global-markets
The synthetic-biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engine that drives the development of the synthetic biology industry. Core products and technologies—standardized DNA parts, synthetic genes and chassis organisms—are the key tools by which cellular factories and systems produce enabled products.
Products enabled by synthetic biology tools—pharmaceuticals, chemicals, biofuels and agricultural— have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. For example, synthetic biology has simplified the commercialization pathway for genome-edited crops in the agriculture industry and enhanced the availability, quality control and testing of novel synthetic genes in the drug development industry.Report Scope
The scope of this study includes core synthetic biology products (synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-free systems and production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, gene editing, bioinformatics and specialty media) and enabled technologies (healthcare, industrial chemicals, consumer products, food and beverages, and agriculture) that are already commercialized or are forecast to be commercialized within the next five years.
We analyze key synthetic biology technologies and products to determine present and future market status and forecasted growth from 2017 through 2022. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces.
BCC Research examines the synthetic biology industry by market segment, including the following segments: DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, software, and the following enabled products sectors: agriculture, consumer products, cosmetics/skin care, food and beverages, healthcare, and industrial chemicals.
The role of key strategic alliances and acquisitions from 2016 through 2017 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, genome-edited crops, and chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 185 companies in these fields are highlighted.
Report Includes
- An overview of the global markets for synthetic biology
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
- Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
- Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture
- Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
- Assessments of the products and technologies most commercially viable now and in the near future
- Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc
Leave a Query @ https://www.wiseguyreports.com/enquiry/2820006-synthetic-biology-global-markets
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Overview
Chapter 4 Market and Technology Background
Chapter 5 Synthetic Biology Applications
Chapter 6 Synthetic Biology Industry
Chapter 7 Synthetic Biology Markets
Chapter 8 Patents
Chapter 9 Synthetic Biology Company Profiles
20N LABS INC.
ABEONA THERAPEUTICS INC.
ACTIVE MOTIF
AEMETIS INC.
AGENOVIR
AGERIA
AGILENT TECHNOLOGIES INC.
AGILIS BIOTHERAPEUTICS LLC
AGRIMETIS LLC
AGRIVIDA
ALGENUITY
AMBRX INC.
AMYRIS INC.
ANTHEIA INC.
ARAKNITEK
ARANEX BIOTECH
ARDRA BIO INC.
ARZEDA CORP.
ASTRAZENECA PLC
ATG BIOSYNTHETICS GMBH
ATUM
AVA FOOD LABS INC.
AVIDBIOTICS CORP.
AZARGEN BIOTECHNOLOGIES PTY LTD.
AZITRA INC.
BASF AG
BAYER AG
BELL BIOSYSTEMS
BENCHLING
BETA RENEWABLES
BIOAMBER INC.
BIO BASIC INC.
BIOCAPITAL HOLDINGS LLC.
BIOCELLECTION INC.
BIOMAX INFORMATICS AG
BIOMX LTD.
BIONEER CORP.
BIO S&T INC.
BIOSYNTIA APS
BLUEBIRD BIO INC.
BLUE HERON BIOTECH LLC
BLUE MARBLE BIOMATERIALS
BOLT THREADS
BRISTOL-MYERS SQUIBB COMPANY
CALYSTA INC.
CALYXT INC.
CARGILL, INC.
CARIBOU BIOSCIENCES INC.
CASZYME
CATALOG TECHNOLOGIES INC.
CELL DESIGN LABS
CELLECTIS SA
CELL FREE TECHNOLOGY LTD.
CHAIN BIOTECHNOLOGY LTD
CIBUS INC.
CLARA FOODS CO.
C-LECTA GMHB
CODAGENIX INC.
CODEXIS, INC.
CORBION BIOTECH INC.
DEMURIS LTD.
DESKTOP GENETICS LTD.
DNA SCRIPT
DOWDUPONT, INC.
EDITAS MEDICINE INC.
EGENESIS INC.
ELIGO BIOSCIENCE
ENBIOTIX INC.
ENEVOLV INC.
EPIBIOME INC.
EPOCH LIFE SCIENCE INC.
EUROFINS MWG OPERON
EVONETIX
EVOLVA SA
EXONICS THERAPEUTICS INC.
EXXONMOBIL CORP.
GEA ENZYMES
GELTOR INC.
GENEDESIGN, INC.
GENEMED SYNTHESIS, INC.
GENE ORACLE INC.
GENERAY BIOTECH CO. LTD.
GENOMATICA
GENSCRIPT
GEVO, INC.
GINKGO BIOWORKS
GLAXOSMITHKLINE PLC
GLOBAL BIOENERGIES
GLOWEE
GLYCOSBIO FOOD SCIENCES
GOODYEAR TIRE & RUBBER CO.
GREEN BIOLOGICS LTD.
HELIXWORKS TECHNOLOGIES LTD.
HOMOLOGY MEDICINES
HORIZON DISCOVERY GROUP PLC
HUVEPHARMA
ILLUMINA, INC.
IMPOSSIBLE FOODS INC.
INDUSTRIAL MICROBES INC.
INGENZA LTD.
INOVIO PHARMACEUTICALS INC.
INTEGRATED DNA TECHNOLOGIES INC.
INTELLIA THERAPEUTICS
INTERNATIONAL BUSINESS MACHINES
INTREXON CORP.
JUNO THERAPEUTICS INC.
KANEKA CORP.
LABGENIUS LTD.
LANZATECH
LATTICE AUTOMATION INC.
LC SCIENCES
LOCUS BIOSCIENCES
LUMEN BIOSCIENCE
LYGOS INC.
MERCK & CO.
METAMIXIS
MICHELIN SA
MICROBYRE
MICROSOFT CORP.
MILIS BIO LTD.
MIRACULEX
MODERN MEADOW
MODULAR GENETICS INC.
MOLECULAR ASSEMBLIES INC.
MORPHOSYS AG
MUSE BIOTECHNOLOGY INC.
MYRIANT CORP.
NEW ENGLAND BIOLABS
NOVARTIS PHARMA AG
NOVOME BIOTECHNOLOGIES INC.
NOVOZYMES A/S
NOVVI LLC
NUCELIS LLC
NUCLERA NUCLEICS LTD.
OMEGA BIO-TEK INC.
ORAGENICS INC.
OXFORD GENETICS LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PERFECT DAY INC.
PFIZER, INC.
PHYLOGICA LTD.
PHYTOWELT GREEN TECHNOLOGIES GMBH
PIVOT BIO
POSEIDA THERAPEUTICS INC.
PRECISION BIOSCIENCES
PROKARIUM HOLDINGS LTD.
QTEROS INC.
RADIANT GENOMICS INC.
RENNOVIA INC.
REVERDIA
ROYAL DSM NV
SAMPLE6 TECHNOLOGIES
SANGAMO THERAPEUTICS INC.
SCARAB GENOMICS LLC
SGI-DNA INC.
Shanghai SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
SIGMA ALDRICH CORP.
SILICOLIFE LDA.
SOLIGENIX INC.
SPIBER INC.
STRING BIO
SUGARLOGIX
SYNBIOTA
SYNBIO TECHNOLOGIES CO., LTD.
SYNLOGIC
SYNPROMICS LTD.
SYNTHACE LTD.
SYNTHEGO CORP.
SYNTHETIC BIOLOGICS INC.
SYNTHETIC GENOMICS, INC.
SYNTHORX INC.
SYNVITROBIO INC.
TAXA BIO-ENGINEERING
TEEWINOT LIFE SCIENCES CORP.
TEPHA, INC.
TESELAGEN BIOTECHNOLOGY INC.
THERMO FISHER SCIENTIFIC, INC.
TRANSCRIPTIC, INC.
TRITON ALGAE INNOVATIONS LTD.
TWIST BIOSCIENCE
TYSON FOODS INC.
UBA BIOLOGIX
VEDANTA BIOSCIENCES
VERDEZYNE INC.
XYCROBE THERAPEUTICS INC.
YIELD10 BIOSCIENCES
ZIOPHARM ONCOLOGY INC.
ZYMERGEN
ZYMOCHEM INC.
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2820006
Continued...
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!